Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04362696 · ClinicalTrials.gov registry record · NA
Improving Working Memory in Older Adults
A NA study of Large-scale Physiological Foundations of Memory Decline in Aging Humans, sponsored by Boston University Charles River Campus.
- Completed
- Registry status
- NA
- Development phase
- 964
- Enrollment target
- 1
- Study location
NCT04362696: Completed NA study of Large-scale Physiological Foundations of Memory Decline in Aging Humans, sponsored by Boston University Charles River Campus.
NCT04362696 is a NA study of Large-scale Physiological Foundations of Memory Decline in Aging Humans that has completed, run by Boston University Charles River Campus. The registered enrollment target is 964 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (31% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04362696, a NA study of Large-scale Physiological Foundations of Memory Decline in Aging Humans, has completed, sponsored by Boston University Charles River Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 964 participants
- Enrollment target
- 1
- Study location
Study Summary
The research program will evaluate the theoretical claim that age-related memory and cognitive decline in humans result from the inefficient orchestration of rhythmic activity within large-scale cortical networks. The results will contribute to the basic science groundwork for developing future non-pharmacological interventions aimed at boosting memory and cognition in aging and clinical populations.
Primary Outcome
The accuracy of task performance (in percentage correct units) in the delayed-match-to-sample working memory paradigm
Conditions Studied
Interventions
- DEVICE High definition transcranial electrical current stimulation
Study Locations (1)
Massachusetts
- 677 Beacon St. Room 308 - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 964 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What the finished NCT04362696 record still lists
NCT04362696 is an interventional study that assigns participants to a tested intervention. The registered 964 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (31% lower).
The record links to 1 condition, with Large-scale Physiological Foundations of Memory Decline in Aging Humans appearing as the primary indexed condition, and to 1 intervention - of which High definition transcranial electrical current stimulation is the first listed.
NCT04362696 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04362696 about?
NCT04362696 is a clinical study titled "Improving Working Memory in Older Adults". The research program will evaluate the theoretical claim that age-related memory and cognitive decline in humans result from the inefficient orchestration of rhythmic activity within large-scale cortical networks. The results will contribute to the basic science groundwork for developing future non-...
What is the current status of trial NCT04362696?
This trial is currently completed. It is a NA study. The enrollment target is 964 participants. The study started on 2019-09-01. Estimated completion is 2025-04-30.
What conditions does trial NCT04362696 study?
This clinical trial studies the following conditions: Large-scale Physiological Foundations of Memory Decline in Aging Humans.
What interventions are being tested in trial NCT04362696?
The interventions under investigation include: High definition transcranial electrical current stimulation (DEVICE).
Who is sponsoring clinical trial NCT04362696?
This trial is sponsored by Boston University Charles River Campus, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04362696 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04362696's enrollment target sits among peer trials
964 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05178498 · 960 participants
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- NCT05946629 · 960 participants · NA
SELUTION 4 De Novo Small Vessel IDE Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI